Keyphrases
Novel Oral Anticoagulants
100%
Stroke Prevention
100%
Left Atrial Appendage
100%
Atrial Fibrillation
36%
1-year Mortality
27%
Low Risk
18%
Impaired Renal Function
18%
Hospitalization
9%
Comorbidity
9%
No Significant Difference
9%
Treatment Strategy
9%
Adverse Effects
9%
Chi-square
9%
Retrospective Comparison
9%
Patient Characteristics
9%
Confounding Variables
9%
Multivariable Cox Regression
9%
Student's T-test
9%
Outpatient Clinic
9%
Renal Function
9%
Baseline Characteristics
9%
Creatinine Clearance
9%
1-year Survival
9%
Follow-up Data
9%
Survival Analysis
9%
Pooled Analysis
9%
Kaplan-Meier Survival Curves
9%
Log-rank Test
9%
Propensity Score
9%
CHA2DS2-VASc Score
9%
Civil Registry
9%
Clinic Notes
9%
Medicine and Dentistry
Apoplexy
100%
Antithrombotic
100%
Anticoagulation
100%
Atrial Fibrillation
44%
Kidney Function
33%
Outpatient
11%
Survival Rate
11%
Proportional Hazards Model
11%
Adverse Event
11%
Creatinine Clearance
11%
Patient Characteristics
11%
Student T Test
11%
Kaplan Meier Method
11%
Pooled Analysis
11%
Survival Analysis
11%
Log Rank Test
11%
CHA2DS2-VASc Score
11%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
100%
Anticoagulation
100%
Kidney Function
75%
Survival Rate
50%
Comorbidity
25%
Student's t-Test
25%
Creatinine Clearance
25%